Financial Engines Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Sell
71,800
-11,575
-14% -$2.57M 0.03% 88
2025
Q4
$19.1M Buy
83,375
+936
+1% +$213K 0.04% 79
2025
Q3
$19.1M Sell
82,439
-4,106
-5% -$836K 0.04% 77
2025
Q2
$16.1M Buy
86,545
+4,515
+6% +$839K 0.03% 79
2025
Q1
$17.2M Buy
82,030
+4,155
+5% +$808K 0.04% 72
2024
Q4
$13.8M Sell
77,875
-219
-0.3% -$40.3K 0.03% 86
2024
Q3
$15.4M Sell
78,094
-2,516
-3% -$470K 0.03% 72
2024
Q2
$13.8M Buy
80,610
+4,345
+6% +$720K 0.03% 76
2024
Q1
$13.9M Sell
76,265
-8,729
-10% -$1.5M 0.03% 69
2023
Q4
$13.2M Buy
84,994
+563
+0.7% +$82.1K 0.03% 69
2023
Q3
$12.6M Sell
84,431
-6,696
-7% -$983K 0.03% 66
2023
Q2
$12.3M Sell
91,127
-4,767
-5% -$699K 0.03% 71
2023
Q1
$15.3M Sell
95,894
-2,542
-3% -$389K 0.04% 65
2022
Q4
$15.9M Buy
98,436
+12,184
+14% +$1.87M 0.05% 72
2022
Q3
$11.6M Sell
86,252
-13,687
-14% -$1.96M 0.04% 73
2022
Q2
$15.3M Sell
99,939
-5,587
-5% -$854K 0.05% 63
2022
Q1
$17.1M Sell
105,526
-4,803
-4% -$698K 0.05% 62
2021
Q4
$14.9M Buy
110,329
+6,251
+6% +$738K 0.04% 57
2021
Q3
$11.2M Sell
104,078
-6,833
-6% -$781K 0.03% 59
2021
Q2
$12.5M Sell
110,911
-16,404
-13% -$1.85M 0.04% 55
2021
Q1
$13.8M Sell
127,315
-3,461
-3% -$370K 0.04% 54
2020
Q4
$14M Buy
130,776
+19,057
+17% +$1.83M 0.05% 56
2020
Q3
$9.79M Sell
111,719
-8,905
-7% -$838K 0.04% 58
2020
Q2
$11.8M Sell
120,624
-13,699
-10% -$1.21M 0.05% 54
2020
Q1
$10.2M Sell
134,323
-13,939
-9% -$1.19M 0.06% 54
2019
Q4
$13.1M Buy
148,262
+8,481
+6% +$704K 0.06% 44
2019
Q3
$10.6M Buy
139,781
+25,741
+23% +$1.76M 0.06% 42
2019
Q2
$8.29M Sell
114,040
-15,071
-12% -$1.18M 0.05% 44
2019
Q1
$10.4M Buy
129,111
+14,143
+12% +$1.16M 0.06% 40
2018
Q4
$10.6M Sell
114,968
-12,370
-10% -$1.09M 0.07% 40
2018
Q3
$11.9M Sell
127,338
-12,748
-9% -$1.21M 0.23% 18
2018
Q2
$13M Sell
140,086
-14,850
-10% -$1.45M 0.31% 17
2018
Q1
$14.7M Sell
154,936
-20,101
-11% -$2.21M 0.43% 15
2017
Q4
$16.9M Sell
175,037
-49,775
-22% -$4.69M 0.49% 15
2017
Q3
$20M Sell
224,812
-17,555
-7% -$1.34M 0.67% 12
2017
Q2
$17.6M Buy
242,367
+21,039
+10% +$1.41M 0.81% 11
2017
Q1
$14.4M Buy
221,328
+26,766
+14% +$1.68M 0.68% 10
2016
Q4
$12.2M Sell
194,562
-9,070
-4% -$554K 0.6% 9
2016
Q3
$12.8M Buy
203,632
+33,998
+20% +$2.2M 10.24% 2
2016
Q2
$10.5M Sell
169,634
-57,472
-25% -$3.5M 8.81% 2
2016
Q1
$13M Buy
227,106
+49,365
+28% +$2.75M 10.76% 2
2015
Q4
$10.5M Sell
177,741
-109,015
-38% -$6.28M 8.42% 2
2015
Q3
$15.6M Sell
286,756
-262,317
-48% -$17.1M 10.96% 2
2015
Q2
$36.9M Buy
+549,073
New +$35.8M 21.89% 1

Other funds holding ABBV

Financial Engines Advisors's ABBV Position: Q1 2026 in Review

Financial Engines Advisors reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $2.57M and leaving 71,800 shares worth $15.6M. The position accounts for 0.03% of the portfolio, ranked #88.

Financial Engines Advisors first reported a position in ABBV in Q2 2015 and has held it in 44 quarters since. The position peaked at $36.9M in Q2 2015. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Financial Engines Advisors held 71,800 shares of AbbVie worth $15.6M as of Q1 2026.
  • Financial Engines Advisors sold 11,575 AbbVie shares in Q1 2026, an estimated $2.57M.
  • AbbVie made up 0.03% of Financial Engines Advisors's portfolio in Q1 2026, its #88 holding.
  • Financial Engines Advisors first reported a position in AbbVie in Q2 2015 and has held it in 44 quarters since.
  • Financial Engines Advisors's AbbVie position peaked at $36.9M in Q2 2015.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Engines Advisors's 13F filing for Q1 2026, filed 14 May 2026.